PAHC vs TSN

For growth investors, Phibro Animal Health Corporation (PAHC) is the stronger pick with 27.

4% revenue growth year-over-year, versus 2. 1% for Tyson Foods, Inc. (TSN). Phibro Animal Health Corporation (PAHC) offers the better valuation at 36. 3x trailing P/E (14. 2x forward), making it the more compelling value choice. Analysts rate Phibro Animal Health Corporation (PAHC) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Phibro Animal Health Corporation (PAHC) is the cheapest at 36.

3x versus Tyson Foods, Inc. at 49. 9x. On forward P/E, Phibro Animal Health Corporation is actually cheaper at 14. 2x.

Over the past 5 years, Phibro Animal Health Corporation (PAHC) delivered a total return of +66.

0%, compared to -1. 6% for Tyson Foods, Inc. (TSN). Over 10 years, the gap is even starker: PAHC returned +128. 6% versus TSN's +23. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Tyson Foods, Inc.

(TSN) is the lower-risk stock at 0. 33β versus Phibro Animal Health Corporation's 1. 38β — meaning PAHC is approximately 315% more volatile than TSN relative to the S&P 500. On balance sheet safety, Tyson Foods, Inc. (TSN) carries a lower debt/equity ratio of 48% versus 3% for Phibro Animal Health Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Phibro Animal Health Corporation (PAHC) is pulling ahead at 27.

4% versus 2. 1% for Tyson Foods, Inc. (TSN). On earnings-per-share growth, the picture is similar: Phibro Animal Health Corporation grew EPS 1883% year-over-year, compared to -39. 6% for Tyson Foods, Inc.. Over a 3-year CAGR, PAHC leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Phibro Animal Health Corporation (PAHC) is the more profitable company, earning 3.

7% net margin versus 0. 9% for Tyson Foods, Inc. — meaning it keeps 3. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PAHC leads at 8. 5% versus 2. 6% for TSN. At the gross margin level — before operating expenses — PAHC leads at 30. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Phibro Animal Health Corporation (PAHC) trades at 14.

2x forward P/E versus 17. 5x for Tyson Foods, Inc. — 3. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PAHC: 13. 5% to $49. 00.

All stocks in this comparison pay dividends.

Tyson Foods, Inc. (TSN) offers the highest yield at 2. 9%, versus 1. 1% for Phibro Animal Health Corporation (PAHC).

For long-horizon retirement investors, Tyson Foods, Inc.

(TSN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), 2. 9% yield). Both have compounded well over 10 years (TSN: +23. 1%, PAHC: +128. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PAHC (Healthcare) and TSN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PAHC is a small-cap high-growth stock; TSN is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.